Talzenna Capsule
Product Images NDC 0069-1501

20 FDA label images from Pfizer Laboratories Div Pfizer Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Talzenna (NDC 0069-1501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Talzenna 01)

Chemical Structure (Talzenna 01)
Chemical structure of the active ingredient in Talzenna, showing a complex molecular structure with fluorine atoms and a sulfonic acid derivative, consistent with a targeted pharmaceutical compound.*
FDA Label Image

Figure 1 (Talzenna 02)

Figure 1 (Talzenna 02)
A Kaplan-Meier plot showing progression-free survival probability (%) over time (months) comparing Talzenna (solid line) and chemotherapy (dashed line). The chart illustrates higher survival probabilities for Talzenna throughout the study period, with patient counts at risk provided below the time axis for both groups.*
FDA Label Image

Figure 2 (Talzenna 03)

FDA Label Image

Figure 3 (Talzenna 04)

FDA Label Image

Figure 4 (Talzenna 04a)

Figure 4 (Talzenna 04a)
A Kaplan-Meier overall survival probability chart compares Talzenna plus Enzalutamide versus Placebo plus Enzalutamide over time in months. The y-axis shows overall survival probability percentage, and the x-axis shows overall survival time in months up to about 64 months. The chart includes the number of patients at risk for both groups listed below the x-axis.*
FDA Label Image

Figure 5 (Talzenna 04b)

Figure 5 (Talzenna 04b)
A Kaplan-Meier survival curve chart showing the probability of progression-free survival (PFS) over time in months. The chart compares two groups: Talzenna plus Enzalutamide (solid line) and Placebo plus Enzalutamide (dashed line). Below the x-axis, the number of patients at risk at various time points for each group is also displayed.*
FDA Label Image

Logo (Talzenna 05)

Logo (Talzenna 05)
Talzenna 0.25 mg capsules label by Pfizer Laboratories Div Pfizer Inc. The label shows the active ingredient talazoparib, with a package size of 30 capsules. It includes storage instructions and prompts to see accompanying prescribing information. The label is marked Rx only.*
FDA Label Image

Logo (Talzenna 06)

Logo (Talzenna 06)
Packaging label for Talzenna 0.25 mg capsules (talazoparib) by Pfizer Laboratories Div Pfizer Inc. The label shows a box design for a 30-capsule bottle, with the strength prominently displayed as 0.25 mg. The label includes storage instructions, dosage use instructions, and manufacturer details including 'Made in Germany' and distributed by Pfizer Labs, Division of Pfizer Inc, New York.*
FDA Label Image

Principal Display Panel (0.25 mg Capsule Bottle Label)

Principal Display Panel (0.25 mg Capsule Bottle Label)
Label for Talzenna (talazoparib) capsules, 1 mg strength, manufactured by Pfizer Laboratories Div Pfizer Inc. The label indicates a quantity of 30 capsules, includes storage instructions at 20°C to 25°C, and notes it is Rx only. The label also shows the NDC 0069-1195-30 and a barcode.*
FDA Label Image

Principal Display Panel (0.25 mg Capsule Bottle Carton)

Principal Display Panel (0.25 mg Capsule Bottle Carton)
The packaging label for Talzenna (talazoparib) capsules, 1 mg strength, containing 30 capsules. The label shows the Pfizer logo and specifies that it is Rx only. Storage instructions and distributor details (Pfizer Labs, New York, NY) are visible. The product is made in Germany.*
FDA Label Image

Principal Display Panel (1 mg Capsule Bottle Label)

Principal Display Panel (1 mg Capsule Bottle Label)
This packaging label is for Talzenna (talazoparib) capsules 0.5 mg, manufactured by Pfizer Laboratories Div Pfizer Inc. The label includes storage instructions, dosage use notice, and indicates a package size of 30 capsules. It also displays the NDC number 0069-1501-30, barcode, and prescription-only status.*
FDA Label Image

Principal Display Panel (1 mg Capsule Bottle Carton)

Principal Display Panel (1 mg Capsule Bottle Carton)
Packaging label for Talzenna 0.5 mg capsules by Pfizer Laboratories Div Pfizer Inc. The label indicates the active ingredient talazoparib, with a package containing 30 capsules. It includes storage instructions, dosage and use notes, and states the product is made in Germany.*
FDA Label Image

Principal Display Panel (0.5 mg Capsule Bottle Label)

Principal Display Panel (0.5 mg Capsule Bottle Label)
Label for Talzenna (talazoparib) capsules 0.75 mg by Pfizer Laboratories Division Pfizer Inc. The label states storage instructions, dosage information, and quantity of 30 capsules. It includes barcode, lot, and expiration placeholders.*
FDA Label Image

Principal Display Panel (0.5 mg Capsule Bottle Carton)

Principal Display Panel (0.5 mg Capsule Bottle Carton)
Carton label for Talzenna capsules 0.75 mg (talazoparib), distributed by Pfizer Laboratories Division of Pfizer Inc. The label states 30 capsules per package and Rx only. Storage instructions and dosage cautions are included, along with barcodes and manufacturing details indicating it is made in Germany.*
FDA Label Image

Principal Display Panel (0.75 mg Capsule Bottle Label)

Principal Display Panel (0.75 mg Capsule Bottle Label)
Talzenna (talazoparib) capsules label showing 0.75 mg strength. The label states 30 capsules per package, Rx only. It includes storage instructions, dosage unit per capsule, distributor as Pfizer Labs, and has several barcodes. The label displays the Pfizer logo and NDC 0069-1751-30.*
FDA Label Image

Principal Display Panel (0.75 mg Capsule Bottle Carton)

Principal Display Panel (0.75 mg Capsule Bottle Carton)
Packaging label for Talzenna 0.75 mg capsules by Pfizer Laboratories Div Pfizer Inc. The label shows the proprietary name Talzenna with the active ingredient talazoparib and strength 0.75 mg. The package contains 30 capsules and is labeled Rx only. Storage and dosage instructions are included, along with barcode and distribution details. The label also indicates the product is made in Germany.*
FDA Label Image

Principal Display Panel (0.1 mg Capsule Bottle Label)

Principal Display Panel (0.1 mg Capsule Bottle Label)
Talzenna 0.1 mg capsules label by Pfizer Laboratories Div Pfizer Inc. The label indicates storage conditions, capsule content of 0.1 mg talazoparib, package quantity of 30 capsules, and notes Rx only.*
FDA Label Image

Principal Display Panel (0.1 mg Capsule Bottle Carton)

Principal Display Panel (0.1 mg Capsule Bottle Carton)
Packaging label for Talzenna 0.1 mg capsules (talazoparib) by Pfizer Laboratories Div Pfizer Inc. The label indicates a package containing 30 capsules with the strength clearly marked as 0.1 mg. Storage and dosage instructions are included, along with barcodes and manufacturing details showing the product is made in Germany.*
FDA Label Image

Principal Display Panel (0.35 mg Capsule Bottle Label)

Principal Display Panel (0.35 mg Capsule Bottle Label)
Talzenna 0.35 mg (talazoparib) capsules packaging label showing a 30-capsule bottle. The label includes storage instructions to keep at 20°C to 25°C with excursions permitted between 15°C to 30°C, dosage note advising to see accompanying prescribing information, and a note that each capsule contains 0.35 mg talazoparib equivalent to 0.509 mg talazoparib tosylate. Distributed by Pfizer Laboratories Division of Pfizer Inc, New York, NY.*
FDA Label Image

Principal Display Panel (0.35 mg Capsule Bottle Carton)

Principal Display Panel (0.35 mg Capsule Bottle Carton)
Packaging label for Talzenna 0.35 mg capsules (talazoparib) by Pfizer. The label is for a 30-capsule bottle with multiple panels including storage instructions, dosage information, distributor details, and barcodes. The product is prescription only and made in Germany.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.